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Abstract
Background: Bluetongue virus (BTV) is a double-stranded RNA (dsRNA) virus of the Reoviridae family, which
encodes its genes in ten linear dsRNA segments. BTV mRNAs are synthesised by the viral RNA-dependent RNA
polymerase (RdRp) as exact plus sense copies of the genome segments. Infection of mammalian cells with BTV
rapidly replaces cellular protein synthesis with viral protein synthesis, but the regulation of viral gene expression in
the Orbivirus genus has not been investigated.
Results: Using an mRNA reporter system based on genome segment 10 of BTV fused with GFP we identify the
protein characteristic of this genus, non-structural protein 1 (NS1) as sufficient to upregulate translation. The wider
applicability of this phenomenon among the viral genes is demonstrated using the untranslated regions (UTRs) of
BTV genome segments flanking the quantifiable Renilla luciferase ORF in chimeric mRNAs. The UTRs of viral mRNAs
are shown to be determinants of the amount of protein synthesised, with the pre-expression of NS1 increasing the
quantity in each case. The increased expression induced by pre-expression of NS1 is confirmed in virus infected
cells by generating a replicating virus which expresses the reporter fused with genome segment 10, using reverse
genetics. Moreover, NS1-mediated upregulation of expression is restricted to mRNAs which lack the cellular 30 poly
(A) sequence identifying the 30 end as a necessary determinant in specifically increasing the translation of viral
mRNA in the presence of cellular mRNA.
Conclusions: NS1 is identified as a positive regulator of viral protein synthesis. We propose a model of translational
regulation where NS1 upregulates the synthesis of viral proteins, including itself, and creates a positive feedback
loop of NS1 expression, which rapidly increases the expression of all the viral proteins. The efficient translation of
viral reporter mRNAs among cellular mRNAs can account for the observed replacement of cellular protein synthesis
with viral protein synthesis during infection.
Keywords: Bluetongue, NS1, Translation, Protein synthesis
Background
Bluetongue virus (BTV) is the prototype member of the
Orbivirus genus of the Reoviridae family. BTV is an arbo-
virus vectored between ruminant hosts by biting midges
of the Culicoides genus [1,2], causing disease in wild and
domesticated ruminants, including sheep, goats and cat-
tle. The virus has a global distribution which has extended
into mainland Europe since 1998 and has caused a severe
economic impact on European livestock farming [3,4]. BTV
has a segmented genome consisting of ten linear double-
stranded RNA (dsRNA) molecules [5,6]. Like other mem-
bers of the Reoviridae the viral messenger RNA (mRNA) is
synthesised by transcription of the double-stranded RNA
(dsRNA) genome segments which remain packaged within
the uncoated core particle [7-9]. The ten viral mRNAs are
synthesised as complete end-to-end copies of the genome
segments by the RNA-dependent RNA polymerase (RdRp)
component of the transcription complexes, VP1, present at
the vertices of the core particle [9-11]. Before extrusion
into the cytosol each transcript is capped and methy-
lated by VP4 at the 50 end, to produce a cap1 structure
(7mGpppGm) identical to that found in cellular mes-
senger RNAs [12-14]. The 50 cap1 structure is almost
ubiquitous among cellular mRNAs and is important
for mRNA stability and efficient translation [15]. The
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30 end of viral transcripts lack a poly(A) tail, which
normally functions in eukaryotic mRNAs to increase
the rate of translation initiation and RNA stability [15-18].
Following the infection of mammalian cells BTV proteins
rapidly accumulate to be the most abundant cytoplasmic
proteins, with the viral proteins being the major products
of active translation by 8 hours post-infection [19]. This
rapid replacement of cellular protein synthesis with viral
protein synthesis indicates that BTV has effective mech-
anism(s) for ensuring the translation of its mRNA, but
how the viral mRNAs of orbiviruses effectively compete
with cellular mRNAs for translation has not been
addressed to date.
A characteristic of Orbivirus infections is the accumu-
lation of highly abundant cytoplasmic tubular structures
composed of the 64 kDa non-structural protein 1 (NS1),
for which no homologue has been found in other genera
of the Reoviridae [20-22]. NS1 is the most highly
expressed BTV protein, becoming the most abundant
cytoplasmic protein before completion of the replication
cycle. Understanding of the functions of NS1 remains
limited to a proposed role in regulating the mechanism
of virus release from the mammalian and insect host
cells [23]. In this model the high ratio of NS1 to NS3 in
mammalian cells is correlated with cell lysis, and the
higher level of NS3 expression observed in Culicoides
cells is correlated with non-lytic release and persistent
infection in culture.
Here we use a synthetic mRNA reporter assay system
to screen the BTV gene products for upregulation of the
expression of a reporter gene consisting of a fusion be-
tween the termini of segment 10 and GFP. The mRNA
reporter contains GFP flanked by the 50 end (152nt) and
30 end (149nt) of segment 10, creating a reporter mRNA
which has both termini of segment 10. Using this ap-
proach NS1 is identified as sufficient to upregulate the
reporter protein abundance. The specificity of NS1 for
viral mRNAs is investigated using reporter mRNAs consis-
ting of BTV untranlsated regions (UTRs) flanking the re-
porter ORF, and using mRNAs with 30 poly(A) extensions.
Using the reverse genetics system we demonstrate that
NS1-dependent upregulation of gene expression also
occurs in the context of viral replication in infected BSR
cells. To our knowledge this is the first report addressing
how orbiviruses upregulate their gene expression.
Results
The expression of BTV genes increases the expression of
a chimeric genome segment 10 - GFP reporter transcript
It remains unknown how orbiviruses regulate translation
of their mRNAs, and which viral proteins are involved.
To investigate the regulation of gene expression an RNA
reporter assay was designed using a capped reporter
transcript, S10-GFP, containing the GFP ORF fused
between the 50 and 30 ends of genome segment 10
(Figure 1A). The BTV 50 end sequence was generated
using a T7 promoter, and the BTV 30 end sequence was
generated using a BsmBI cleavage site as previously
described in the establishment of a BTV reverse genetics
system [24]. To express all the BTV genes without the
rapid lysis produced by BTV infection, viral mRNA gene-
rated in vitro by transcribing cores were used. Confluent
BSR monolayers were transfected with capped S10-GFP
reporter RNA alone or in combination with viral mRNA
to provide the complete complement of BTV-1 genes. In
the absence of BTV gene expression the S10-GFP reporter
produced a detectable low level of fluorescence, but coex-
pression of the BTV gene products increased the level of
GFP markedly (Figure 1B and C). The increased accumu-
lation of the reporter strongly suggests that the BTV ge-
nome encodes a factor which increases the expression of
the NS3 protein encoded by segment 10.
NS1 expression is sufficient to increase the expression of
the segment 10 - GFP reporter transcript
Each BTV gene was tested individually to remove the pos-
sibility that the increased reporter expression observed
(Figure 1) was due to replication of the reporter RNA. To
determine whether any BTV gene product individually
upregulates expression from the S10-GFP reporter RNA,
each of the ten BTV-10 genes was expressed from the
strong CMV/chicken actin hybrid promoter of the
pCAGGS vector [25]. To screen the BTV genes, BSR
monolayers were transfected with each pCAG clone
18 hours prior to transfection with the S10-GFP reporter
transcript. The fluorescence produced with each BTV
protein was recorded 20 hours after transfection with the
S10-GFP RNA. Only NS1 expression was found to in-
crease the expression from the S10-GFP reporter RNA
significantly and no effect on the expression level was
observed with the other nine BTV gene products
(Figure 2A). To determine the optimal dose for further
study the dose–response relationship was tested across a
range of pCAG NS1 quantities (Figure 2B, C). The
increased translation of the reporter RNA was detectable
at 12.5 ng pCAG NS1 per well and found to increase up
to 100 ng (Figure 2B). Significant toxicity was observed
with 200 ng pCAG NS1 and a standard quantity of 100 ng
at 96 well plate scale was chosen for further investigation.
NS1 regulated expression is not mediated through
interaction with NS3
The protein encoded by the S10-GFP reporter RNA con-
sists of GFP fused in frame with both termini of the NS3
protein encoded by segment 10. A proposed role for
NS1 is its involvement in determining whether lysis is
the ultimate fate of the infected cell [23]. BTV infection
of mammalian cells is lytic, but in cells derived from the
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Culicoides insect vector the infection is persistent with
continual virus release. The ratio of NS3 to NS1 was
suggested to control whether lysis occurred, with the
higher level of NS3 expression in insect cells preventing
lysis induced by NS1 [23]. To address the possibility that
the upregulation of the S10-GFP reporter RNA is indica-
tive of an interaction between NS1 and the remaining
NS3 protein sequences in the reporter protein a series of
S10-GFP variants were made. Each variant retains both
the 50 and 30 ends of segment 10, but the length of the
NS3 protein sequence fused to the GFP reporter is
reduced or eliminated by the destruction of the NS3 ini-
tiation codons, or the creation of termination codons or
frameshifts (Figure 3A). The expression of all variants was
found to be responsive to NS1 including mutant 5 which
has no NS3 sequence in-frame with the GFP protein. This
demonstrates that NS1 does not increase the abundance of
the reporter protein through an interaction with NS3
sequences (Figure 3B), and suggests it acts through the re-
porter RNA itself.
To confirm that the choice of reporter gene was not
responsible for the observed NS1 dependant increase in
abundance, and to generate a sensitive assay with which
the level of activation could be quantified, the luciferase
based reporter, pS10-Rluc was constructed. The GFP
ORF in pS10-GFP was replaced with the Renilla lucifer-
ase ORF (Figure 4A). To measure the responsiveness of
the S10-Rluc RNA to NS1 the transfections were per-
formed as described for S10-GFP, and the luciferase ac-
tivity in the cell lysates was quantified. The luciferase
expression in S10-Rluc RNA transfected cell lysates was
also found to be increased by coexpression of NS1, with
a 15–20 fold increase in expression of luciferase being
typical of NS1 pre-expression (Figure 4B). The sensitivity
gained by measuring luminescence allowed even the
relatively low expression of the reporter in the absence
A
B C
Figure 1 Expression of BTV genes upregulates expression from capped S10-GFP RNA. (A) pS10-GFP contains the 50 152nt and 30 149nt of
BTV-10 segment 10 fused in frame with GFP. The 50 end of the capped S10-GFP reporter RNA is defined by the T7 promoter (italicised) and the 30
end is determined by a BsmBI site (underlined). (B) and (C) Confluent 24 well BSR monolayers fixed in 4% PFA at 22 h post-transfection. (B)
Transfected with 1 μg capped S10-GFP reporter RNA alone. (C) Transfected with 1 μg capped S10-GFP reporter RNA+ 0.8 μg BTV-1 mRNA
produced in vitro from transcribing cores as previously described [35].
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of NS1 to be detected at over 105 relative light units,
extending the utility of the RNA reporter assay to poorly
expressed variants.
NS1 increases protein expression from reporter mRNAs
containing the UTRs of BTV genes
To establish whether NS1 is a specific regulator of ex-
pression from segment 10 or has a more general role in
viral gene expression a series of reporters were made
containing the 50 UTR and 30 UTR of five BTV seg-
ments, S1 (VP1), S4 (VP4), S6 (NS1), S8 (NS2) or S10
(NS3) from BTV-1, where the viral ORF is replaced by
the Renilla luciferase ORF (Figure 5A). The effect of the
UTRs from these segments on the expression of lucifer-
ase was measured in the presence and absence of NS1
in the RNA reporter assay (Figure 5B). Each reporter
RNA was responsive to NS1, demonstrating that the
UTRs are sufficient to confer NS1-responsiveness to the
corresponding viral genes, and indicating a general role
for NS1 in upregulating the expression of BTV protein.
There was variation between the genome segments in
the quantity of luciferase expressed from the UTR re-
porter transcripts in the absence of NS1. This shows
that the UTRs of the BTV genes are determinants of the
relative expression levels of the viral mRNAs.
NS1 increases the expression of Renilla luciferase
incorporated into the genome of BTV-1
To determine whether NS1 increases the expression of a
protein encoded by the BTV genome the chimeric S10-
Rluc RNA was recovered into the genome of BTV-1. The
S10-Rluc RNA was rescued in the genome of BTV-1 to
make BTV-1 S10Rluc virus by using the reverse genetics
system with the BSR NS3 line, which complements the
absence of functional NS3 [24,26]. The T7 transcripts
used in the RNA transfection reporter assay in previous
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Figure 2 Expression from capped S10-GFP RNA is upregulated by NS1. (A) BSR 96 well monolayers transfected with 100 ng BTV pCAG
clones or empty pCAGGS vector together with 100 ng capped S10-GFP reporter RNA. Fluorescence was recorded at 20 h after transfection with
capped S10-GFP reporter RNA. (B) Dose–response relationship of expression from capped S10-GFP RNA across a two-fold dilution series of NS1
expression. BSR 96 well monolayers transfected with 0 ng - 200 ng pCAG NS1 and the capped S10-GFP reporter RNA. Fluorescence was recorded
at 20 h after transfection with S10-GFP reporter RNA at low magnification (10x objective lens) to maximise the number of cells within the field of
view. Values indicate the number of fluorescing cells within the field. (C) Expression of NS1 in BSR 96 well monolayers transfected with the same
quantities of pCAG NS1 used in panel B. Transfected monolayers were harvested at 18 h after transfection and analysed by SDS-PAGE, followed
by immunoblotting using anti-NS1 rabbit polyclonal antibody R633. The quantities above the lanes indicate the amount of plasmid transfected.
NS1 positive control -2 μg BTV-10 NS1 purified from Sf9 cells infected with recombinant baculovirus Ac BTV NS1. The numbering on the left
indicates the molecular weight of the size markers.
Boyce et al. Virology Journal 2012, 9:178 Page 4 of 11
http://www.virologyj.com/content/9/1/178
experiments were capped with the anti-reverse cap
analogue which is known to substitute for a cap 1 struc-
ture in the translation of cellular mRNAs [27]. To deter-
mine whether NS1 upregulates expression from an
mRNA transcribed and capped by the core particle in the
context of virus replication the expression of the Rluc re-
porter from the viral genome was quantified in infected
cells. BSR cells were transfected with pCAG NS1 or
pCAGGS and infected with BTV-1 S10Rluc after
20 hours. The amount of luciferase was measured at
1 hour intervals, to quantify the effect of NS1 on expres-
sion at early times. In this system also the luciferase ac-
tivity was found to be higher when BSR cells had been
transfected in advance with pCAG NS1, with a marked
increase in luciferase expression directly after infection
(Figure 6A, B). These data confirmed that NS1 increases
expression from transcripts produced from transcribing
cores, and showed that the early expression of NS1 is im-
portant for the upregulation of viral gene expression.
30 poly(A) tailing of mRNA prevents NS1 mediated
upregulation
The 30 poly(A) sequence is a near-universal feature of cellu-
lar transcripts which is absent in the mRNA of orbiviruses.
BTV infection replaces cellular protein synthesis with viral
protein synthesis [19], but how the cellular gene expression
is shut off has not been studied. The efficient competition
of viral mRNA translation over cellular translation is one
possibility. To address the specificity of NS1-mediated
upregulation of gene expression the NS1-responsiveness of
a 30 polyadenylated Renilla luciferase reporter with no viral
sequences present was tested, as a proxy for a cellular
mRNA. The Renilla luciferase transcript was synthesised
from XbaI-digested pRL-null (Promega) and poly(A) tailed
to generate Rluc(A)n mRNA. In vitro polyadenylation with
E.coli poly(A) polymerase was confirmed by the slower mi-
gration rate using denaturing agarose gel electrophoresis
(Figure 7A). The NS1-responsive expression observed
for the S10-Rluc mRNA was not seen with the Rluc(A)n
mRNA (Figure 7B, C). To determine whether a 30 poly
(A) tail is sufficient for NS1 to discriminate between
viral and cellular mRNAs the NS1-responsive S10-Rluc
mRNA was polyadenylated (Figure 7A). The resulting
S10-Rluc(A)n mRNA was found to be unresponsive to
NS1 (Figure 7B, C). The almost complete abrogation of
the NS1-responsive phenotype by the addition of a poly
(A) sequence demonstrates that the 30 ends of BTV
transcripts are critical determinants in the mechanism
A
B
Figure 3 NS1 does not act through NS3 sequences in the reporter protein. (A) pS10-GFP mutants contain point mutations which reduce or
eliminate the regions of NS3 fused to GFP. Mut1, introduced termination codon and −1 frame shift at C-terminus of GFP. Mut2, NS3 initiation
codon destroyed. Mut 4, NS3 initiation codon and 2nd methionine codon destroyed. Mut5, NS3 initiation codon and 2nd methionine codon
destroyed, and at the C-terminus of GFP a termination codon and −1 frame shift were introduced. (B) BSR 96 well monolayers transfected with
100 ng pCAG NS1 and capped S10-GFP RNA mutants. Fluorescence was recorded at 20 h after transfection with reporter RNAs.
Boyce et al. Virology Journal 2012, 9:178 Page 5 of 11
http://www.virologyj.com/content/9/1/178
of NS1 regulated expression. These data show that NS1 is
not acting as a global upregulator of translation or of pro-
tein stability, but suggest that NS1 specifically increases the
expression of viral mRNA over cellular transcripts.
Discussion
The BTV proteins have been shown to be the most
highly expressed genes in BHK cells by 8 hours post in-
fection [19]. The approach used here identifies the tu-
bule forming protein characteristic of orbiviruses, NS1,
as a positive regulator of the translation of viral mRNAs.
The screen of the BTV genes for proteins which regulate
the expression from the segment 10-GFP mRNA identi-
fied NS1 as sufficient, and no effect on GFP expression
was observed with other BTV proteins. This approach
demonstrates that NS1 is a positive regulator of BTV
gene expression, but the possibility that complexes con-
taining more than one viral protein also regulate BTV
gene expression is not excluded.
The increased expression was also found when the re-
porter mutants retained the 50 and 30 regions of segment
10, but did not encode the amino and carboxy termini
of NS3. The NS1-responsiveness of these variants
demonstrates that the short NS3 protein sequences
fused to GFP cannot be responsible for the increased ac-
cumulation of the reporter protein. This was confirmed
by the NS1 responsiveness of transcripts which consist
of only the UTRs of BTV mRNAs fused to the Renilla
luciferase ORF. Together these results suggest that NS1
acts at the level of the mRNA to either increase its sta-
bility and therefore abundance, or increase the rate at
which it is used as a template in translation.
The fusion of the Renilla luciferase gene with segment
10 in the S10-Rluc mRNA produced a quantitative and
more sensitive reporter system for measuring NS1 re-
sponsiveness, with NS1 enhancing the expression from
the S10-Rluc mRNA in transfected cells by 15–20 fold.
The upregulation of expression from reporter mRNAs
B
A
Figure 4 Expression from capped S10-Rluc RNA is upregulated by NS1. (A) pS10-Rluc contains the 50 152nt and 30 149nt of BTV-10 segment
10 fused with the Renilla luciferase gene. (B) BSR 96 well monolayers transfected with 100 ng pCAG NS1 and capped S10-Rluc RNA mutants. The
amount of luciferase present in the transfected cell lysates was assayed in triplicate at 20 h after transfection with S10-Rluc reporter RNA. Bars
indicate one standard deviation from the mean.
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containing the UTRs of five BTV genes demonstrates that
NS1-dependent gene expression is not restricted to the ex-
pression of the NS3 protein from segment 10, but is a wider
phenomenon affecting the expression of other BTV genes.
Importantly, the type of transcripts upregulated by NS1
does not extend to the Rluc(A)n mRNA which lacks viral
sequences and has a typical cellular 30 poly(A) tail, demon-
strating that NS1 is not a general upregulator of expression
from all mRNAs. The 30 extension of the NS1-responsive
S10-Rluc mRNA with a poly(A) sequence was sufficient to
prevent increased expression, showing that the nature of
the 30 end of the mRNA is crucial to the upregulation func-
tion of NS1. Moreover the absence of upregulation of the
polyadenylated mRNAs confirms that NS1 does not in-
crease viral gene expression by globally increasing protein
stability. Together these data support a model where NS1
is a positive regulator of viral mRNA expression, but does
not increase the expression of cellular mRNAs. The com-
petitive advantage this would give to the translation of
viral transcripts can account for the replacement of cellu-
lar protein synthesis with viral protein synthesis in BTV
infected BHK cells [19].
The BTV UTRs themselves were found be one level of
regulation of the expression of the viral proteins, with
the absolute levels of expression from each of the UTR-
containing reporters varying markedly between the seg-
ments. This variation occurred both in the presence and
absence of NS1 pre-expression, with NS1 increasing the
quantity of luciferase produced from each mRNA by
10–30 fold. The BTV UTRs were found to be determi-
nants of the protein expression level as is established for
the UTRs of cellular mRNAs [28], and the upregulatory
effect of NS1 is an additional level of regulation. The
contribution of the UTRs to the expression level is par-
ticularly marked for the segment 6 UTRs which flank
the NS1 gene itself, the most highly expressed BTV gene
during infection. In this case the level of translation seen
in the absence of NS1 is already high, and the absolute
quantity of luciferase produced when NS1 is upregulat-
ing expression is higher than the other UTRs tested.
When rescued into the genome of infectious virus
using the reverse genetics system, the expression of the
S10-Rluc reporter genome segment was also responsive
to NS1. The expression of NS1 using pCAG NS1
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Figure 5 Expression from capped transcripts containing both UTRs of segments 1, 4, 6, 8 or 10 is responsive to NS1. (A) The 50 +30 UTR
constructs contain the 50 UTR and 30 UTR of BTV-1 segments 1 (VP1), 4 (VP4), 6 (NS1), 8 (NS2), or 10 (NS3) immediately flanking the Renilla
luciferase ORF. The 50 end of the capped reporter RNAs are defined by a T7 promoter and the 30 end is determined by a BsmBI site, as described
in Figure 1. (B) BSR 96 well monolayers transfected with 100 ng pCAG NS1 and capped reporter transcripts. The amount of luciferase was assayed
in triplicate 20 h after transfection with the reporter RNAs. Bars indicate one standard deviation from the mean. Fold of NS1-dependent
upregulation indicated.
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increased the expression of the reporter at early time
points, demonstrating that the NS1-dependent upregula-
tion occurs in the context of virus replication where the
viral mRNA is synthesised by transcriptionally active
cores. The diminishing effect observed with time is an
expected consequence of the abundant and rapid synthe-
sis of NS1 by the infecting virus, which would be
expected to rapidly exceed the initial difference in NS1
abundance between cells transfected with pCAG NS1
and those transfected with the pCAGGS vector. The
higher level of reporter expression seen at early times
after infection with the BTV-1 S10Rluc virus demon-
strates the competitive advantage given to viral gene ex-
pression by the presence of NS1 in the infected cells.
Indeed the recovery of viruses by reverse genetics with
no NS1 initiation codon, or coding changes which abro-
gate the regulatory function was not possible (data not
shown). Knockdown by siRNA of the moderate level of
NS1 expression from pCAG NS1, compared to BTV in-
fection, have been insufficient to reduce reporter activity
by more than 2 fold (data not shown). This observation
is consistent with the amount of NS1 produced by trans-
fection with small quantities of pCAG NS1 plasmid
being sufficient to highly upregulate expression from re-
porter mRNAs (Figure 2B).
NS1 performing the role of a positive regulator of
BTV gene expression is consistent with it being the most
highly expressed BTV protein encoded by the most
Figure 7 30 Polyadenylation of reporter mRNA abrogates NS1-responsiveness. (A) Denaturing 1% agarose gel electrophoresis of T7
transcripts generated from XbaI digested pRL-null (Promega) and BsmBI digested pS10-RLuc. Lane 1, Rluc transcript, lane 2, Rluc transcript after 30
polyadenylation with poly(A) polymerase, lane 3, S10-Rluc transcript, lane 4, S10-Rluc transcript after 30 polyadenylation with poly(A) polymerase.
M, 1 μg of ssRNA markers (Promega), with length indicated in nucleotides. (B) BSR 96 well monolayers transfected with 100ng pCAG NS1 and
capped reporter transcripts. The amount of luciferase was assayed in triplicate 20 h after transfection with the reporter RNAs. Values are relative
light units (RLU) expressed as the mean of three replicates. (C) Effect of 30 poly(A) tail on fold upregulation of expression in response to NS1. Bars
indicate one standard deviation from the mean.
Figure 6 NS1 upregulates expression of the rescued S10-Rluc reporter segment in replicating BTV-1 S10Rluc. (A) 96 well monolayers
were transfected with 100 ng pCAG NS1 or pCAGGS vector, and infected with BTV-1 S10Rluc. The amount of luciferase was assayed in triplicate
at 1 h intervals following infection with the BTV-1 S10Rluc reporter virus. Values are relative light units (RLU) expressed as the mean of three
replicates. (B) Graph of the fold increase of the virus expressed reporter in NS1 expressing cells compared to vector transfected BSR. Values are
the fold increase observed when NS1 was pre-expressed. Bars indicate one standard deviation from the mean.
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abundant transcript produced by transcribing BTV cores
[9,19]. We propose a model of translational regulation in
which NS1 increases the expression of the BTV genes,
including itself, creating a positive feedback loop of NS1
expression which increases the rate of synthesis of all
the viral proteins, as has been found for the rotavirus
NSP3 protein [29]. The increased translation of viral
transcripts in the presence of NS1 suggests that a com-
petitive advantage is given to the translation of viral
transcripts over cellular polyadenylated mRNAs, and is
consistent with the observed shutdown of cellular gene
expression and its simultaneous replacement with viral
gene expression in BTV infected cells by 8 hours p.i.
reported by Huismans [19]. Altogether the data pre-
sented here demonstrate that the effective competition
of viral mRNAs with cellular mRNAs, mediated by NS1,
is one way that this is achieved. BTV NS1 and rotavirus
NSP3 do not share amino acid sequence homology and
are not similar size proteins (64 kDa versus 34 kDa re-
spectively), but NS1 clearly performs the translational
upregulation function also reported for rotavirus NSP3
[29-32], although the mechanism leading to increased
expression in the presence of NS1 remains to be eluci-
dated. The existence of cis-acting sequences within the
viral UTRs, particularly the 30 UTR, which allow NS1 to
discriminate between viral mRNAs and cellular mRNAs, is
one prediction of the model which is being investigated.
Conclusions
This is the first report addressing how orbiviruses replace
cellular protein synthesis with viral protein synthesis. NS1
is identified as sufficient to increase protein synthesis from
chimeric virus-reporter gene mRNAs in both transfected
and infected cells. The UTRs of segments 1, 4, 6, 8, and 10
are sufficient to confer NS1-responsiveness to protein syn-
thesis. The abrogation of NS1 responsiveness by 30 poly(A)
extension of the mRNA demonstrates that the 30 end is a
critical determinant of NS1 responsiveness. Knowledge of
the structure of NS1 and its interaction with viral mRNAs
will be important in understanding how NS1 specifically
increases viral protein synthesis in orbiviruses.
Methods
Cell lines and virus
BSR cells (a BHK-21 subclone) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 5%
(v/v) foetal bovine serum (FBS) at 35°C in 5% CO2. The
NS3 expressing cell line BSR NS3 was cultured in the pre-
sence of puromycin (7.5 μgml-1) [26].
BTV-1 stocks were generated by infecting BSR cells at
a multiplicity of infection (MOI) of 0.1 and harvesting
the medium at 3 days for wildtype BTV-1 or 7 days for
BTV-1 S10-Rluc. Viral stocks were stored at 4°C.
Infection of transfected BSR cells with BTV-1 S10-Rluc
reporter virus
Transfected BSR cells were infected at an MOI of 1 at
room temperature for 45 minutes. Wells were washed
four times in PBS, and incubated in DMEM supplemen-
ted with 5% (v/v) FBS at 35°C in 5% CO2.
T7 promoter plasmid clones used for the synthesis of
reporter transcripts
The GFP-containing clone pS10-GFP consists of the 50
152nt and 30 149nt of BTV-10 segment 10 fused in frame
with the GFP ORF. Mutants of pS10-GFP which did not
fuse the remaining BTV protein coding sequences to GFP
were generated by site directed mutagenesis using the
method of Weiner et al. [33], with the primer pairs
S10GFP_mut1F and S10GFP_mut1R (mutants 1 and 5),
S10GFP_mut2F and S10GFP_mut2R (mutants 2, 4, and 5),
S10GFP_mut3F and S10GFP_mut3R (mutants 4 and 5),
S10GFP_mut4F and S10GFP_mut4R (mutants 4 and 5).
The Renilla luciferase-containing clone pS10-Rluc con-
sists of the 50 152nt and 30 149nt of BTV-10 segment 10
fused in frame with the Rluc ORF.
The Renilla luciferase clones containing the 50 and 30
UTRs of segments 1, 4, 6, 8 or 10 of BTV-1 consist of the
Renilla luciferase ORF immediately flanked by the UTRs.
The pRL-null (Promega) vector contains the Renilla
luciferase ORF downstream of a T7 promoter.
BTV protein expression plasmids
BTV protein expression plasmids were generated by clo-
ning the ten BTV-10 ORFs downstream of the chicken β
actin promoter of the pCAGGS expression vector reported
previously [25], to generate pCAG VP1, pCAG VP2, pCAG
VP3, pCAG VP4, pCAG VP5, pCAG VP6, pCAG VP7,
pCAG NS1, pCAG NS2 and pCAG NS3.
Synthesis of reporter RNAs
Synthetic single-stranded RNAs were prepared by run-
off in vitro transcription from BsmBI digested plasmid
clones, using T7 RNA polymerase. Transcripts were pre-
pared with anti-reverse cap analogue (ARCA) from lin-
ear plasmid DNA using the mMESSAGE mMACHINE
T7 Ultra kit (Ambion) as previously described [24]. Poly
(A) tailed transcripts were generated using poly(A) poly-
merase according to the manufacturer’s instructions.
Denaturing agarose gel electrophoresis
Transcripts were analysed under denaturing conditions
by electrophoresis on 1% agarose in morpholinepropane-
sulfonic acid (MOPS) electrophoresis buffer in the pres-
ence of formaldehyde [34].
Boyce et al. Virology Journal 2012, 9:178 Page 9 of 11
http://www.virologyj.com/content/9/1/178
Immunoblot analysis of pCAG NS1 transfected BSR cells
Samples were resolved in 10% SDS-PAGE gels and
transferred to nitrocellulose membranes. Standard im-
munoblotting techniques were used with rabbit poly-
clonal antiserum R633 raised against NS1. Proteins
were visualised using alkaline phosphatase-conjugated
goat anti-rabbit IgG (Sigma) with BCIP/NBT substrate
(Sigma).
Purification of BTV core particles
BSR cultures were infected with BTV at an MOI of 0.1.
Transcriptionally active BTV-1 core particles were puri-
fied as previously described and stored at 4°C [35].
Synthesis and purification of BTV mRNA in vitro
BTV core particles were incubated at 40 μgml-1 at
30°C for 5 to 6 h in core transcription buffer
(100 mM Tris HCl pH8.0, 4 mM ATP, 2 mM GTP,
2 mM CTP, 2 mM UTP, 500 μM S-adenosylmethio-
nine, 6 mM DTT, 9 mM MgCl2, 0.5U μl
-1 RNAsin
Plus [Promega]). BTV core-derived mRNAs were
purified as previously described [35], followed by an
additional precipitation in isopropanol and resuspen-
sion in DEPC-treated water.
Transfection of BSR cells with BTV protein expression
plasmids
70-90% confluent BSR monolayers in 96 well plates were
transfected with plasmid DNA using Lipofectamine
2000™ reagent (Invitrogen), according to the manufac-
turer’s instructions. Incubation of transfected cells was
continued at 35°C in 5% CO2.
Transfection of BSR cells with reporter mRNA transcripts
Growth medium was replaced with 100 μl fresh growth
medium 18 h after transfection with BTV protein ex-
pression plasmids. Reporter transcripts were diluted in
OptiMEM-1, 0.1U μl-1 RNAsin Plus (Promega), before
mixing with Lipofectamine™ 2000 reagent. Monolayers
were transfected with 25 ng of the reporter transcript
unless otherwise indicated, and incubated at 35°C in 5%
CO2 for 20 h.
Quantification of reporter expression
GFP expression in transfected BSR cells was visua-
lised using a Nikon Eclipse TS100 microscope and
recorded using a Nikon Coolpix 995 digital camera,
with the number of fluorescing cells per visual field
recorded. When transfection included a complete in-
fectious set of BTV genome segments then fixation
in 4% paraformaldehyde in PBS for 10 minutes was
performed prior to recording fluorescence.
The expression of Renilla luciferase in transfected
or infected BSR cells was quantified with a Turner
Biosystems Glomax luminometer using the Dual
Luciferase Reporter Assay System (Promega) or the
Renilla Luciferase Assay System (Promega), according
to the manufacturer’s instructions. The mean and
standard deviation were calculated for triplicate mono-
layers transfected or infected in 96 well plates.
Transfection of BSR cells to generate BTV-1 S10Rluc
reporter virus
The S10-Rluc reporter RNA was rescued into the BTV-1
genetic background as previously described, using the
BSR NS3 cell line to complement deletion of the NS3
ORF [24,26].
Primers
Mutagenic primers used to generate variants of pS10-
GFP were the following:
Mutants 1 and 5 (Introduce a termination codon at the
C terminus of the GFP ORF and a −1 frame shift of
NS3 relative to GFP); S10GFP_mut1F (50GGCATGGA
CGAGCTGTACAAGTAAGTGGAAGTTCAAGATC
TATCCCG30) and S10GFP_mut1R (50CGGGATAGAT
CTTGAACTTCCACTTACTTGTACAGCTCGTCC
ATGCC30).
Mutants 2, 4 and 5 (NS3 initiation codon changed to
AAG); S10GFP_mut2F (50CTATAGTTAAAAAGTGTC
GCTGCCAAGCTATCCGGGCTGATCC30) and
S10GFP_mut2R
(50GGATCAGCCCGGATAGCTTGGCAGCGACAC
TTTTTAACTATAG30).
Mutant 4 and 5 (NS3 2nd ATG codon changed to
ACG); S10GFP_mut3F
(50CCAAAGGTTCGAAGAAGAAAAGACGAAACAC
AATCAAGATAGAGTTGAAG30) and S10GFP_mut3R
(50CTTCAACTCTATCTTGATTGTGTTTCGTCTTT
TCTTCTTCGAACCTTTGG30).
Mutants 4 and 5 (Reading frame altered so that GFP is
in the +1 frame compared to NS3 N terminus);
S10GFP_mut4F (50CGAGTGCACCGACGCGTATCC
AGTGGTGGAGGTATGGTG30) and S10GFP_mut4R
(50CACCATACCTCCACCACTGGATACGCGTCGG
TGCACTCG30).Mutagenic bases are underlined.
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